NCT02983006 Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE1
NCT02974335 A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 1 Status COMPLETED Phase N/A
NCT02970981 Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma Status COMPLETED Phase PHASE2
NCT02968940 Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma Status COMPLETED Phase PHASE2
NCT02963948 A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 3 Status COMPLETED Phase N/A
NCT02955108 The Effect of Distractive Auditory Stimuli (Music) on Dyspnea and Anxiety During Exercise in Adults With Chronic Respiratory Diseases Status COMPLETED Phase NA
NCT02955095 Usability and Pilot Testing - Intervention for Smoking Cessation Status WITHDRAWN Phase NA
NCT02945839 Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department Status WITHDRAWN Phase PHASE4
NCT02936479 C1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft Rejection Status COMPLETED Phase PHASE2
NCT02935946 Cold Liquids Fed to Preterm Infants: Efficacy and Safety After 10 Minutes of Exposure Status COMPLETED Phase NA
NCT02935790 Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab Status COMPLETED Phase PHASE1
NCT02934503 Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) Status TERMINATED Phase PHASE2